bioAffinity Technologies, Inc. (NASDAQ:BIAF) IPO will take place August, 25 on the NASDAQ exchange under the ticker BIAF.
The company is offering shares at an expected price between $6.00 and $6.25 per share with an insider lock-up period of 180 days ending on February 21, 2023.
See also: Benzinga IPO Calendar
About bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. is a privately held company incorporated in Delaware addressing the need for noninvasive diagnosis of early-stage cancer and diseases of the lung, and targeted cancer treatment.
See also: Benzinga’s Most Shorted Stocks
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
